German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L04AC07" (16)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Tocilizumab (L04AC07) 16 products
WHO-DDD
DrugBank.ca
L
SIP
IP
CI
Actemra 200 mg/10 ml
Durchstechflasche(n)
231.93
267.35
10 %
Concentrate for infusion: Tocilizumabum 200mg / 10ml
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
SIP
IP
CI
Actemra 400 mg/20 ml
Durchstechflasche(n)
463.85
518.30
10 %
Concentrate for infusion: Tocilizumabum 400mg / 20ml
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
SIP
IP
CI
Actemra 80 mg/4 ml
Durchstechflasche(n)
92.77
116.80
10 %
Concentrate for infusion: Tocilizumabum 80mg / 4ml
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
IP
CI
Actemra 162 mg/0.9 ml
4
962.96
1042.95
10 %
Injektionslösung in einem Fertigpen zur subkutanen Anwendung: Tocilizumabum 162mg / 0.9ml
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
IP
CI
Actemra 162 mg/0.9 ml
4 Fertigspritze(n)
962.96
1042.95
10 %
Injektionslösung zur subkutanen Anwendung: Tocilizumabum 162mg / 0.9ml
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
IP
CI
Avtozma 162mg/0.9 ml
4
625.92
697.15
10 %
iQone Healthcare
Switzerland SA
A / SL / SG
FB
G
L
IP
CI
Avtozma 162 mg/0.9 ml
4
625.92
697.15
10 %
iQone Healthcare
Switzerland SA
A / SL / SG
FB
G
L
IP
Avtozma 80 mg/ 4ml
84.34
108.15
10 %
Concentrate for infusion: Tocilizumabum 80mg / 10ml
iQone Healthcare
Switzerland SA
A / SL / SG
FB
G
L
IP
Avtozma 200 mg/10 ml
210.85
245.75
10 %
Concentrate for infusion: Tocilizumabum 200mg / 10ml
iQone Healthcare
Switzerland SA
A / SL / SG
FB
G
L
IP
Avtozma 400 mg/20 ml
421.71
475.05
10 %
Concentrate for infusion: Tocilizumabum 400mg / 20ml
iQone Healthcare
Switzerland SA
A / SL / SG
FB
G
L
IP
Tocilizumab Spirig HC 80
mg/4 ml
84.34
108.15
10 %
Concentrate for infusion: Tocilizumabum 80mg / 4ml
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Tocilizumab Spirig HC 200
mg/10 ml
210.85
245.75
10 %
Concentrate for infusion: Tocilizumabum 200mg / 10ml
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Tocilizumab Spirig HC 400
mg/20 ml
421.71
475.05
10 %
Concentrate for infusion: Tocilizumabum 400mg / 20ml
Spirig HealthCare AG
A / SL / SG
FB
G
IP
Tocilizumab Spirig HC 80
mg/4 ml
4
k.A.
Concentrate for infusion: Tocilizumabum 80mg / 4ml
Spirig HealthCare AG
A
FB
G
IP
Tocilizumab Spirig HC 200
mg/10 ml
4
k.A.
Concentrate for infusion: Tocilizumabum 200mg / 10ml
Spirig HealthCare AG
A
FB
G
IP
Tocilizumab Spirig HC 400
mg/20 ml
4
k.A.
Concentrate for infusion: Tocilizumabum 400mg / 20ml
Spirig HealthCare AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
